[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI1572233T1 - Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 - Google Patents

Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68

Info

Publication number
SI1572233T1
SI1572233T1 SI200332003T SI200332003T SI1572233T1 SI 1572233 T1 SI1572233 T1 SI 1572233T1 SI 200332003 T SI200332003 T SI 200332003T SI 200332003 T SI200332003 T SI 200332003T SI 1572233 T1 SI1572233 T1 SI 1572233T1
Authority
SI
Slovenia
Prior art keywords
hpv18
hpv16
vaccine against
hpv type
oncogenic hpv
Prior art date
Application number
SI200332003T
Other languages
Slovenian (sl)
Inventor
Gary Dubin
Bruce Innis
Moncef M Slaoui
M A C Wettendorff
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Priority claimed from EP03789346A external-priority patent/EP1572233B1/en
Publication of SI1572233T1 publication Critical patent/SI1572233T1/en

Links

SI200332003T 2002-12-20 2003-12-18 Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 SI1572233T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43503502P 2002-12-20 2002-12-20
US49665303P 2003-08-20 2003-08-20
EP03789346A EP1572233B1 (en) 2002-12-20 2003-12-18 Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
PCT/EP2003/014562 WO2004056389A1 (en) 2002-12-20 2003-12-18 Hpv-16 and -18 l1 vlp vaccine

Publications (1)

Publication Number Publication Date
SI1572233T1 true SI1572233T1 (en) 2011-07-29

Family

ID=36166935

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332003T SI1572233T1 (en) 2002-12-20 2003-12-18 Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68

Country Status (4)

Country Link
CN (1) CN100418577C (en)
SI (1) SI1572233T1 (en)
UA (1) UA85377C2 (en)
ZA (1) ZA200504907B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101116745B (en) * 2006-08-04 2011-05-11 长春百克生物科技股份公司 Human papilloma virus sample particle vaccines
CN101181636B (en) * 2006-11-14 2010-09-15 北京金迪克生物技术研究所 Compound vaccine composition for preventing and controlling human viral infection, compound vaccine vaginal mist and uses thereof
PL2444103T3 (en) * 2009-06-19 2018-05-30 Eyegene Inc. Vaccine for cervical cancer
CN102349996B (en) * 2011-10-17 2014-06-25 沈阳三生制药有限责任公司 Human papilloma virus pharmaceutical composition and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition

Also Published As

Publication number Publication date
UA85377C2 (en) 2009-01-26
CN1747745A (en) 2006-03-15
CN100418577C (en) 2008-09-17
ZA200504907B (en) 2006-08-30

Similar Documents

Publication Publication Date Title
HK1085378A1 (en) Use of hpv16 and hpv18 as vaccine against one or more of oncogenic hpv type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
AP1872A (en) Virus-like particles of human papillomavirus.
NO2012016I1 (en) Combination of HPV16 and HPV18 L1 virus-like particles
AU2003227533A1 (en) Virus like particle from papillomavirus and their use in vaccine
ZA200502618B (en) Human papillomavirus polypeptides and immunogenic compositions
AU2002252949A1 (en) 2-(Alpha-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE
HUS1500061I1 (en) Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
IL179138A0 (en) Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31,45, or 52
AU2003271215A8 (en) Vector for anti-hpv vaccine and transformed microorganism by the vector
AU2003290012A1 (en) L2-peptide of the human papillomavirus associated with virus-like particles
SI1572233T1 (en) Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
GB2383752B (en) Use of strains of the parapox ovis virus against organ fibrosis
GB0200258D0 (en) Detection of human papillomavirus
AU2001285827A2 (en) Use of strains of the parapox ovis virus against organ fibrosis
AU2001285827A1 (en) Use of strains of the parapox ovis virus against organ fibrosis
AU2002236065A1 (en) Papillomavirus vaccines
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
HUP0402069A3 (en) Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the ihnibitor-binding pocket
AU2002318385A1 (en) Geminin and orc3n inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses
AU2003289640A1 (en) Tricyclacetalactonin, Preparation and Use there of
AU2002322573A1 (en) Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin